UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer chemotherapy in the older cancer patient

Urologic oncology, 2009-11, Vol.27 (6), p.633-642

2009

Volltextzugriff (PDF)

Advanced breast cancer at presentation (ABC-p) in octogenarian women (OW): Specific elderly-devoted risk tests(SEDRT) (CARG+CRASH) as new tools to prevent serious/irreversible adverse reactions (AR) in frail patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12510-e12510

2021

Volltextzugriff (PDF)

Prognostic impact of baseline circulating extracellular vesicles (BCEVs) in the setting of patients with advanced non-small cell lung cancer (ANSCLC) eligible for first line treatment with osimertinib

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14553-e14553

2023

Volltextzugriff (PDF)

Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20719-e20719

Carreca, Ignazio Ugo

2013

Volltextzugriff (PDF)

Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10592-10592

2023

Volltextzugriff (PDF)

Fluorine-18 fluorodeoxyglucose ( 18 FDG)-uptake assessment of PDGFRA mutant gastrointestinal stromal tumors (GIST): A retrospective multicenter Italian study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11539-11539

2023

Volltextzugriff (PDF)

Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11571-11571

2023

Volltextzugriff (PDF)

Cell-free DNA and exoDNA analysis in metastatic colorectal cancer patients (mCRC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16093-e16093

2020

Volltextzugriff (PDF)

Effects of erybuline/capecitabine (EC) treatment in very elderly women (VEW) with MBC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e12508-e12508

2017

Volltextzugriff (PDF)

Cancer in the older person

Cancer treatment reviews, 2005-08, Vol.31 (5), p.380-402

2005

Volltextzugriff (PDF)

Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10519-10519

2022

Volltextzugriff (PDF)

Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21525-e21525

2022

Volltextzugriff (PDF)

The role of polymorphisms occurring in BRCA1 /2 genes in determining ovarian cancer risk

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e17551-e17551

2021

Volltextzugriff (PDF)

How to deal with second line dilemma in metastatic colorectal cancer? A systematic review and meta-analysis

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15006-e15006

2019

Volltextzugriff (PDF)

Combination of eribulin (E) and capecitabine (C) in elderly metastatic breast cancer (MBC): Update of a new option suitable in older elderly

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.9540-9540

2015

Volltextzugriff (PDF)

Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14035-e14035

2019

Volltextzugriff (PDF)

Sex and Gender in Ageing and Longevity: Highlights From an International Course

Translational medicine @ UniSa, 2024, Vol.26 (1), p.15

2024

Volltextzugriff (PDF)

Eribulin (E) and capecitabine (C), a combined treatment schedule in elderly metastatic breast cancer (EMBC): Efficacy and safety evaluation (E&S)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20513-e20513

2014

Volltextzugriff (PDF)

Gemcitabine‐based doublets versus single‐agent therapy for elderly patients with advanced nonsmall cell lung cancer

Cancer, 2009-05, Vol.115 (9), p.1924-1931

2009

Volltextzugriff (PDF)

Cancer chemotherapy in the older cancer patient : Geriatric Urologic Oncology: A field Coming of Age

Urologic oncology, 2009, Vol.27 (6), p.633-642

2009

Volltextzugriff (PDF)

Gemcitabine-based Doublets Versus Single-agent Therapy for Elderly Patients With Advanced Nonsmall Cell Lung Cancer : A Literature-based Meta-analysis

Cancer, 2009-05, Vol.115 (9), p.1924-1931

2009

Volltextzugriff (PDF)

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma

Cancer, 2004-01, Vol.100 (2), p.279-287

2004

Volltextzugriff (PDF)

Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14676-e14676

2012

Volltextzugriff (PDF)

The role of myelopoietic growth factors in managing cancer in the elderly

Drugs (New York, N.Y.), 2002, Vol.62 Suppl 1 (Supplement 1), p.47-63

2002

Volltextzugriff (PDF)

Supportive care of the older cancer patient

Critical reviews in oncology/hematology, 2003-10, Vol.48 (Suppl), p.S65-S70

2003

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Journal Of Clinical Oncology
(16)
Cancer
(3)
Critical Reviews In Oncology/hematology
(2)
Drugs
(2)
Oncology
(2)
Urologic Oncology
(2)
American Journal Of Cancer
(1)
Anti-Cancer Drugs
(1)
Anticancer Research
(1)
Cancer Control
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer chemotherapy in the older cancer patient

Advanced breast cancer at presentation (ABC-p) in octogenarian women (OW): Specific elderly-devoted risk tests(SEDRT) (CARG+CRASH) as new tools to prevent serious/irreversible adverse reactions (AR) in frail patients

Prognostic impact of baseline circulating extracellular vesicles (BCEVs) in the setting of patients with advanced non-small cell lung cancer (ANSCLC) eligible for first line treatment with osimertinib

Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation

Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients

Fluorine-18 fluorodeoxyglucose ( 18 FDG)-uptake assessment of PDGFRA mutant gastrointestinal stromal tumors (GIST): A retrospective multicenter Italian study

Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA)

Cell-free DNA and exoDNA analysis in metastatic colorectal cancer patients (mCRC)

Effects of erybuline/capecitabine (EC) treatment in very elderly women (VEW) with MBC

Cancer in the older person

Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)

Immunometabolic predictive factors in Merkel cell carcinoma (MCC) patients treated with avelumab

The role of polymorphisms occurring in BRCA1 /2 genes in determining ovarian cancer risk

How to deal with second line dilemma in metastatic colorectal cancer? A systematic review and meta-analysis

Combination of eribulin (E) and capecitabine (C) in elderly metastatic breast cancer (MBC): Update of a new option suitable in older elderly

Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients?

Sex and Gender in Ageing and Longevity: Highlights From an International Course

Eribulin (E) and capecitabine (C), a combined treatment schedule in elderly metastatic breast cancer (EMBC): Efficacy and safety evaluation (E&S)

Gemcitabine‐based doublets versus single‐agent therapy for elderly patients with advanced nonsmall cell lung cancer

Cancer chemotherapy in the older cancer patient : Geriatric Urologic Oncology: A field Coming of Age

Gemcitabine-based Doublets Versus Single-agent Therapy for Elderly Patients With Advanced Nonsmall Cell Lung Cancer : A Literature-based Meta-analysis

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma

Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome

The role of myelopoietic growth factors in managing cancer in the elderly

Supportive care of the older cancer patient

Suchergebnisse filtern